Epix AI wins Momentum and Jury’s Awards at Dare 2 Scale by Endeavor Bulgaria, highlighting its rapid growth and impact in AI-powered health and longevity solutions.
Epix AI has emerged as the winning participant in Endeavor Bulgaria’s prestigious Dare 2 Scale accelerator program, clinching two out of three major awards – the Momentum Award and the Jury’s Award. This significant recognition further validates Epix AI’s innovative approach and its commitment to enhancing health and longevity through advanced AI solutions.
The Dare 2 Scale program is renowned for promoting companies with exceptional scalability and commercial potential, making Epix AI’s dual win a remarkable achievement. The Momentum Award acknowledges the company’s rapid progress and impactful growth, while the Jury’s Award highlights the exceptional value and future potential of Epix AI’s contributions to the health sector.
“This recognition underscores our dedication to transforming health outcomes through AI-driven solutions,” said Nikolay Vasev, CEO of Epix AI. “Winning these two awards is a testament to our team’s relentless efforts and the positive impact we are creating in the health and longevity space.”
The accolades mark a pivotal moment for Epix AI, positioning it as a rising leader in health-focused AI innovation and reinforcing its trajectory toward global success.